Warning Letter
FDA cites Essential Pharmacy Compounding (Omaha) for bulk-compounding of verterinary drugs.
In a 7 January warning letter (), the US Food and Drug Administration's Kansas City district office (Lenexa, KS) cited Omaha's Essential Pharmacy Compounding for mass-producing veterinary drugs from bulk active pharmaceutical ingredients.
The warning cited large-scale compounding of altrenogest, amikacin sulfate, dipyrone, flunixin belumine, ketoprofen, ivermectin, ompeprazole, phenylbutazone, and tripelemine hydrochoride, "among many others." As is typical in these warnings, the agency voiced concerns that Essential is compounding not for individual patients but for third-party resale, and that the compounded drugs duplicate approved products in dosage and concentration.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
